hypoactive sexual desire disorder

Uro Pipeline: Bladder Ca drug-device combination begins second phase Ib trialA bladder cancer drug-device combination, a localized prostate cancer agent, and a new surgical robot are among other treatments in the pipeline discussed in this round-up.
Taking Sides: Should ob/gyns prescribe flibanserin for their patients?
Taking Sides: Should ob/gyns prescribe flibanserin for their patients?A look at the pros and cons of this new drug for women with low sexual desire.
New Products: FDA approves oral agent for HSDD, app helps men with erectile dysfunction and moreIn this round-up of new urology products and services, learn about the FDA approving an oral agent for HSDD, an app that helps men with erectile dysfunction, and more.
Best of AUA 2014: Sexual Function/Dysfunction
Best of AUA 2014: Sexual Function/DysfunctionLandon Trost, MD, presents the take home messages on sexual function/dysfunction from the AUA annual meeting in Orlando, FL, including studies of clostridium collagenase histolyticum (CCH [XIAFLEX]).
Urology Product Preview April 2014Drugs and devices in the pipeline from Astellas Pharma, Medivation, Repros Therapeutics, Metamark Genetics, Argos Therapeutics, S1 Biopharma, Ipsen, Sprout Pharmaceuticals, Antigen Express, Generex Biotechnology, Veloxis Pharmaceuticals, and Absorption Pharmaceuticals.
Should testosterone therapy be used to treat HSDD in reproductive-aged women?Two experts discuss whether the use of testosterone is ever appropriate for this indication.